Advances in Alzheimer's drug development offer hope for patients
Dr. Jeffrey L. Cummings, UNLV research professor and a leading expert on Alzheimer's disease clinical trials, led a five-year review of all Alzheimer's drugs in the development pipeline. He says today there is more hope than ever that we'll one day solve Alzheimer's.
.png)
No hay comentarios:
Publicar un comentario